Subscribe to our newsletter

Registry Investigator Network

CorEvitas is now part of Thermo Fisher Scientific. Read More.

Our network of investigators collects data directly from patients at the time of routine clinical encounters. Insights derived from this data improve care and health outcomes of patients with chronic autoimmune diseases.

CorEvitas has clinical sites across the U.S., Canada and Japan and we are always interested in expanding the registry for qualified sites.

340,139 +

YEARS OF PATIENT DATA

99,482+

PARTICIPATING PATIENTS

507+

PARTICIPATING SITES

NETWORK BENEFITS

Being a member of the CorEvitas network can help you elevate your practice.

"Private practice is always challenging. CorEvitas has provided our busy clinicians an opportunity to contribute in a meaningful way to important science. The registry adds value to the information we collect in our daily work, and has even created jobs within our practice community."

- Paul H. Caldron, DO

OUR PROCESS

CorEvitas offers qualified clinical sites the opportunity to take part in the data collection process

Before participating, each site must obtain approval from CorEvitas and an Institution Review Board (IRB)

Finally, we ask that each site assign a principal investigator (PI) and a primary registry contact

Rheumatoid arthritis patients talk about their experiences

Want to learn more?